Endogenous retroviruses and multiple sclerosis-new pieces to the puzzle

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Nissen, Kari K ^a   Laska, Magdalena J ^a   Hansen, Bettina ^a   Terkelsen, Thorkild ^a   Villesen, Palle ^a   Bahrami, Shervin ^b   Petersen, Thor ^c   Pedersen, Finn S ^a   Nexø, Bjørn A ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b Incuba Science Park ^*  (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

BST2; Endogenous retroviruses; Genetic association; HERV Fc1; Multiple sclerosis; TRIM

Indexed keywords

GENOMIC DNA; TRIPARTITE MOTIF PROTEIN 5; VIRUS PROTEIN;

ADAPTIVE IMMUNITY; ASTROCYTE; AUTOIMMUNE DISEASE; DISEASE ASSOCIATION; ENDOGENOUS RETROVIRUS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; HUMAN; IN VITRO STUDY; INNATE IMMUNITY; LEUKOCYTE; MULTIPLE SCLEROSIS; NONHUMAN; RETROVIRUS INFECTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC CELL; VIRUS CAPSID; X CHROMOSOME;

CARRIER PROTEINS; ENDOGENOUS RETROVIRUSES; GENETIC MARKERS; HUMANS; MULTIPLE SCLEROSIS;

EID: 84883177675     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-111     Document Type: Review

References (45)

1. Compston A, Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517. 10.1016/S0140-6736(08)61620-7, 18970977.
2. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurological sciences 2001, 22:117-139. 10.1007/s100720170011, 11603614.
3. Dyment DA, Yee IML, Ebers GC, Sadovnick AD. Multiple sclerosis in stepsiblings: recurrence risk and ascertainment. J Neurol Neurosurg Psychiatry 2006, 77:258-259. 10.1136/jnnp.2005.063008, 2077589, 16421134.
4. Ebers GC, Sadovnick AD, Risch NJ. A genetic basis for familial aggregation in multiple sclerosis. Nature 1995, 377:150-151. 10.1038/377150a0, 7675080.
5. Hansen T, Skytthe A, Stenager E, Petersen HC, Brønnum-Hansen H, Kybik KO. Concordance for multiple sclerosis in Danish twins: an update of a nationwide study. Mult Scler 2005, 11:504-510. 10.1191/1352458505ms1220oa, 16193885.
6. Svejgaard A. The immunogenetics of multiple sclerosis. Immunogenetics 2008, 60:275-286. 10.1007/s00251-008-0295-1, 18461312.
7. Sawcer S, Hellenthal G, Pirinen M, Spencer CCA, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, Potter SC, Goris A, Band G, Bang Oturai A, Strange A, Saarela J, Bellenguez C, Fontaine B, Gillman M, Hemmer B, Gwilliam R, Zipp F, Jayakumar A, Martin R, Leslie S, Hawkins S, Giannoulatou E, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476:214-219. 10.1038/nature10251, 3182531, 21833088.
8. Gourraud PA, Harbo HF, Hauser SL, Baranzini SE. The genetics of multiple sclerosis: an up-to-date review. Immunol Rev 2012, 248:87-103. 10.1111/j.1600-065X.2012.01134.x, 22725956.
9. Giovannoni G, Ebers G. Multiple sclerosis: the environment and causation. Curr Opin Neurol 2007, 20:261-268. 10.1097/WCO.0b013e32815610c2, 17495618.
10. Kurtzke JF. Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1993, 6:382-427. 358295, 8269393.
11. Lünemann JD, Kamradt T, Martin R, Münz C. Epstein-barr virus: environmental trigger of multiple sclerosis?. J Virol 2007, 81:6777-6784. 10.1128/JVI.00153-07, 1933281, 17459939.
12. Koprowski H, DeFreitas E, Harper M, Sandberg-Wollheim M, Sheremata W, Robert-Guroff M, Saxinger C, Feinberg M, Wong-Staal F, Gallo R. Multiple sclerosis and human T-cell lymphotropic retroviruses. Nature 1985, 318:154-160. 10.1038/318154a0, 2997627.
13. Pépin M, Vitu C, Russo P, Mornex JF, Peterhans E. Maedi-visna virus infection in sheep: a review. Vet Res 1998, 29:341-367.
14. Gardner M, Kozak C, O'Brien S. The lake Casitas wild mouse: evolving genetic resistance to retroviral disease. Trends Genet 1991, 7:22-27. 10.1016/0168-9525(91)90017-K, 1848377.
15. Clements JE, Mankowski JL, Gama L, Zink MC. The accelerated simian immunodeficiency virus macaque model of human immunodeficiency virus-associated neurological disease: from mechanism to treatment. J Neurovirol 2008, 14:309-317. 10.1080/13550280802132832, 18780232.
16. Grindstaff P, Gruener G. The peripheral nervous system complications of HTLV-1 myelopathy (HAM/TSP) syndromes. Semin Neurol 2005, 25:315-327. 10.1055/s-2005-917668, 16170744.
17. Cermelli C, Jacobson S. Viruses and multiple sclerosis. Viral Immunol 2000, 13:255-267. 10.1089/08828240050144590, 11016591.
18. Perron H, Geny C, Laurent A, Mouriquand C, Pellat J, Perret J, Seigneurin JM. Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res Virol 1989, 140:551-561.
19. Blond JL, Besème F, Duret L, Bouton O, Bedin F, Perron H, Mandrand B, Mallet F. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J Virol 1999, 73:1175-1185. 103938, 9882319.
20. Antony JM, Deslauriers AM, Bhat RK, Ellestad KK, Power C. Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants?. Biochim Biophys Acta 1812, 2011:162-176.
21. Garcia-Montojo M, Dominguez-Mozo M, Arias-Leal A, Garcia-Martinez T, De las Heras V, Casanova I, Faucard R, Gehin N, Madeira A, Arroyo R, Curtin F, Alvarez-Lafuente R, Perron H. The DNA copy number of human endogenous retrovirus-W (MSRV-type) is increased in multiple sclerosis patients and is influenced by gender and disease severity. PloS one 2013, 8:e53623. 10.1371/journal.pone.0053623, 3538585, 23308264.
22. Nexø BA, Christensen T, Frederiksen J, Møller-Larsen A, Oturai AB, Villesen P, Hansen B, Nissen KK, Laska MJ, Petersen TS, Bonnesen S, Hedemand A, Wu T, Wang X, Zhang X, Brudek T, Maric R, Søndergaard HB, Sellebjerg F, Brusgaard K, Kjeldbjerg AL, Rasmussen HB, Nielsen AL, Nyegaard M, Petersen T, Børglum AD, Pedersen FS. The etiology of multiple sclerosis: genetic evidence for the involvement of the human endogenous retrovirus HERV-Fc1. PloS ONE 2011, 6:e16652. 10.1371/journal.pone.0016652, 3032779, 21311761.
23. Hansen B, Oturai AB, Harbo HF, Celius EG, Nissen KK, Laska MJ, Søndergaard HB, Petersen T, Nexø BA. Genetic association of multiple sclerosis with the marker rs391745 near the endogenous retroviral locus HERV-Fc1: analysis of disease subtypes. PLoS ONE 2011, 6:e26438. 10.1371/journal.pone.0026438, 3201946, 22039488.
24. Martinelli-Boneschi F, Esposito F, Brambilla P, Lindström E, Lavorgna G, Stankovich J, Rodegher M, Capra R, Ghezzi A, Coniglio G, Colombo B, Sorosina M, Martinelli V, Booth D, Oturai AB, Stewart G, Harbo HF, Kilpatrick TJ, Hillert J, Rubio JP, Abderrahim H, Wojcik J, Comi G. A genome-wide association study in progressive multiple sclerosis. Mult Scler J 2012, 18:1384-1394.
25. Laska MJ, Brudek T, Nissen KK, Christensen T, Møller-Larsen A, Petersen T, Nexø BA. Expression of HERV-Fc1, a human endogenous retrovirus, is increased in patients with active multiple sclerosis. J Virol 2012, 86:3713-3722. 10.1128/JVI.06723-11, 3302483, 22278236.
26. Nissen KK, Laska MJ, Hansen B, Pedersen FS, Nexø BA. No additional copies of HERV-Fc1 in the germ line of multiple sclerosis patients. Virol J 2012, 9:1-4. 10.1186/1743-422X-9-1, 3305386, 22214262.
27. Laska MJ, Nissen KK, Nexø BA. (Some) cellular mechanisms influencing the transcription of human endogenous retrovirus, HERV-Fc1. PloS one 2013, 8:e53895. 10.1371/journal.pone.0053895, 3557288, 23382858.
28. Strissel PL, Ruebner M, Thiel F, Wachter D, Arif B, Wolf F, Thieme F, Ruprecht K, Matthias W. Reactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: emergence of new molecular targets. Oncotarget 2012, 3:1204-1219. 3717959, 23085571.
29. Schulz WA, Steinhoff C, Florl AR. Methylation of endogenous human retroelements in health and disease. Curr Top Microbiol Immunol 2006, 310:211-250. 10.1007/3-540-31181-5_11, 16909913.
30. Kaiser SM, Malik HS, Emerman M. Restriction of an extinct retrovirus by the human TRIM5alpha antiviral protein. Science 2007, 316:1756-1758. 10.1126/science.1140579, 17588933.
31. Jouvenet N, Neil SJD, Zhadina M, Zang T, Kratovac Z, Lee Y, McNatt M, Hatziioannou T, Bieniasz PD. Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J Virol 2009, 83:1837-1844. 10.1128/JVI.02211-08, 2643743, 19036818.
32. Perez-Caballero D, Soll SJ, Bieniasz PD. Evidence for restriction of ancient primate gammaretroviruses by APOBEC3 but not TRIM5alpha proteins. PLoS Pathog 2008, 4:e1000181. 10.1371/journal.ppat.1000181, 2564838, 18927623.
33. Stetson DB, Ko JS, Heidmann T, Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008, 134:587-598. 10.1016/j.cell.2008.06.032, 2626626, 18724932.
34. Lassmann H, Brück W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathol 2007, 17:210-218. 10.1111/j.1750-3639.2007.00064.x, 17388952.
35. Pertel T, Hausmann S, Morger D, Züger S, Guerra J, Lascano J, Reinhard C, Santoni FA, Uchil PD, Chatel L, Bisiaux A, Albert ML, Strambio-De-Castillia C, Mothes W, Pizzato M, Grütter MG, Luban J. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 2011, 472:361-365. 10.1038/nature09976, 3081621, 21512573.
36. Barber GN. Cytoplasmic DNA innate immune pathways. Immunol Rev 2011, 243:99-108. 10.1111/j.1600-065X.2011.01051.x, 21884170.
37. Baum A, García-Sastre A. Induction of type I interferon by RNA viruses: cellular receptors and their substrates. Amino Acids 2010, 38:1283-1299. 10.1007/s00726-009-0374-0, 2860555,2860555, 19882216.
38. Rolland A, Jouvin-Marche E, Viret C, Faure M, Perron H, Marche PN. The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses. J Immunol 2006, 176:7636-7644.
39. Holm CK, Jensen SB, Jakobsen MR, Cheshenko N, Horan KA, Moeller HB, Gonzalez-Dosal R, Rasmussen SB, Christensen MH, Yarovinsky TO, Rixon FJ, Herold BC, Fitzgerald KA, Paludan SR. Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING. Nat Immunol 2012, 13:737-743. 10.1038/ni.2350, 3411909, 22706339.
40. Sharma P, Azebi S, England P, Christensen T, Møller-Larsen A, Petersen T, Batsché E, Muchardt C. Citrullination of histone H3 interferes with HP1-mediated transcriptional repression. PLoS genetics 2012, 8:e1002934. 10.1371/journal.pgen.1002934, 3441713, 23028349.
41. Mameli G, Poddighe L, Mei A, Uleri E, Sotgiu S, Serra C, Manetti R, Dolei A. Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis. PloS one 2012, 7:e44991. 10.1371/journal.pone.0044991, 3459916, 23028727.
42. Maruszak H, Brew BJ, Giovannoni G, Gold J. Could antiretroviral drugs be effective in multiple sclerosis? a case report. Eur J Neurol 2011, 18:e110-e111. 10.1111/j.1468-1331.2011.03430.x, 21834893.
43. Nexø B, Pedersen L, Sørensen H, Koch-Henriksen N. Treatment of HIV and risk of multiple sclerosis. Epidemiology 2013, 24:331-332.
44. Giovannoni G. Raltegravir (Isentress) Pilot Study in Relapsing Multiple Sclerosis (INSPIRE) 2013, http://clinicaltrials.gov/ct2/show/NCT01767701?term?=?raltegravir?+?and?+?multiple?+?sclerosis&rank?=?1.
45. Curtin F, Lang AB, Perron H, Laumonier M, Vidal V, Porchet HC, Hartung HP. GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical study. Clin Ther 2012, 34:2268-2278. 10.1016/j.clinthera.2012.11.006, 23200102.